E760 Stock Overview
A medical technology company, engages in the development of biopsy system to enhance diagnostics and treatment of breast cancer patients.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
NeoDynamics AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr0.075 |
52 Week High | kr3.34 |
52 Week Low | kr0.06 |
Beta | 1.22 |
1 Month Change | 6.20% |
3 Month Change | 25.67% |
1 Year Change | -97.74% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -98.53% |
Recent News & Updates
Recent updates
Shareholder Returns
E760 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0.3% | 1.4% | 1.1% |
1Y | -97.7% | -3.1% | 6.5% |
Return vs Industry: E760 underperformed the German Medical Equipment industry which returned -3.1% over the past year.
Return vs Market: E760 underperformed the German Market which returned 6.5% over the past year.
Price Volatility
E760 volatility | |
---|---|
E760 Average Weekly Movement | 25.3% |
Medical Equipment Industry Average Movement | 4.6% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.4% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: E760's share price has been volatile over the past 3 months.
Volatility Over Time: E760's weekly volatility has decreased from 87% to 25% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | 9 | Matilda Salen | www.neodynamics.com |
NeoDynamics AB (publ), a medical technology company, engages in the development of biopsy system to enhance diagnostics and treatment of breast cancer patients. It develops NeoNavia, a precision biopsy system that offers clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. The company was incorporated in 2015 and is based in Lidingö, Sweden.
NeoDynamics AB (publ) Fundamentals Summary
E760 fundamental statistics | |
---|---|
Market cap | €2.81m |
Earnings (TTM) | -€7.51m |
Revenue (TTM) | €80.13k |
35.1x
P/S Ratio-0.4x
P/E RatioIs E760 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
E760 income statement (TTM) | |
---|---|
Revenue | kr930.00k |
Cost of Revenue | kr1.50m |
Gross Profit | -kr568.00k |
Other Expenses | kr86.62m |
Earnings | -kr87.19m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 20, 2024
Earnings per share (EPS) | -2.67 |
Gross Margin | -61.08% |
Net Profit Margin | -9,374.95% |
Debt/Equity Ratio | 0% |
How did E760 perform over the long term?
See historical performance and comparison